Portuguese 
English 
Spanish 
3 min of reading 
0 comments 
Amil, Competitor of Unimed, Was Sold for R$ 11 Billion to Businessman José Seripieri Filho and Promises to Become the Largest Health Plan in the Brazilian Market.
Unimed is widely recognized as one of the largest health plan companies in Brazil, but it is far from being the only giant in this highly competitive sector. There are major rivals fiercely competing in the market, and recently, a historic merger caught attention. One of Unimed’s largest competitors, now strengthened by this merger, is positioned to become the largest health plan in the country. Check out the details of this strategic move that promises to transform the landscape of health plans in Brazil, redefining market forces and the options available to consumers.
Unimed Competitor Sold for R$ 11 Billion
Typically, companies unite with the aim of increasing their influence in the industry they operate in. This is a common strategy and usually works very well. There are large enterprises that have simply surged after promoting a merger.
According to newspaper O Globo, in December of last year, the Board of Directors of the American UnitedHealth Group approved the sale of Amil to businessman José Seripieri Filho, known as Júnior and who was the founder of Qualicorp. This deal was valued at R$ 11 billion, one of the largest in the country.
-
“No one will make us change the Pix,” says Lula after the US report.
-
Lula responds directly to Trump and says that Pix is from Brazil and will not change under pressure from anyone, after a report from the United States pointed out the Brazilian payment system as an American trade barrier.
-
Amazon has just announced a new fee on all deliveries, and your online purchases will become more expensive starting April 17, including for those buying from the United States here in Brazil.
-
He sold his share for R$ 4 thousand, saw the company become a giant worth R$ 19 trillion, and missed the opportunity of a lifetime.
The purchase of Unimed’s competitor made Seripieri the official owner of Amil. According to the newspaper, the Americans would not be responsible for anything that happened at Amil. The new owner believes he can restructure the health operator and will do everything to make it one of the most sought after by the public.
The deal will make Amil return to the Top 1 in the health plan sector and shows that the company desires to become a major player in the segment again. This could pose a problem for Unimed, which will face fierce competition from this giant in the sector.
The Process of Selling Amil
Unimed’s competitor in the health plan sector was also being contested, at the time, by businessman Nelson Tanure of the Alliança operator and by the American private equity fund Bain Capital, which was a significant shareholder of NotreDame Intermédica in the country.
In the largest merger and acquisition transaction in the country between an individual and a company, Júnior will pay R$ 2 billion to UHG and assume liabilities of about R$ 9 billion. The total amount, however, could be higher due to potential litigations.
This was Júnior’s strategy, as he takes over the business on a “turnkey” basis even with the risk of facing potential higher expenses in the future. On the other hand, this may also have been the reason why the Americans at Bain withdrew from the competition. If they had stayed, negotiations would have dragged into this year, something that UHG wanted to avoid. When approached, Amil stated that “UnitedHealth Group Brazil does not comment on market speculation.”
Amil Has About 5.4 Million Beneficiaries
The Brazilian operation, for which the company paid nearly R$ 10 billion a decade ago, is small for the size of the American giant, and has losses primarily in individual health plans. Tanure also sought protection against other litigations in his offer.
Amil, a Unimed competitor, is the fourth largest operator in the country, behind NotreDame Intermédica, Hapvida, and Bradesco Saúde, with a 6% market share, according to the ANS. The company has about 5.4 million health and dental plan beneficiaries, 31 hospitals, and 28 medical clinics.
With the deal, Júnior returned to the health sector, where he made his fortune. Known for having built Qualicorp, which became a giant in health plans for class entities, he will face the challenge of getting the finances of a company that currently has negative cash generation, estimated at R$ 2 billion.
Seja o primeiro a reagir!